Bank Of New York Mellon Corp Cyma Bay Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$5.88 - $9.59 $235,088 - $383,417	39,981 New	39,981 $349 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $127,908 - $249,063	39,723 New	39,723 $249,000
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $983 - $1,508	-355 Reduced 1.22%	28,781 $101,000
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $425,923 - $839,465	-247,630 Reduced 89.47%	29,136 $86,000
Q1 2022 May 11, 2022	BUY	$2.77 - $3.64 $60,831 - $79,938	21,961 Added 8.62%	276,766 $861,000
Q4 2021 Feb 11, 2022	BUY	$3.23 - $4.6 $16,179 - $23,041	5,009 Added 2.01%	254,805 $861,000
Q3 2021 Nov 12, 2021	BUY	$3.47 - $4.42 $30,480 - $38,825	8,784 Added 3.64%	249,796 $911,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $4.92 $139,507 - $174,207	-35,408 Reduced 12.81%	241,012 $1.05 Million
Q1 2021 May 13, 2021	SELL	$4.23 - $6.55 $6,666 - $10,322	-1,576 Reduced 0.57%	276,420 $1.25 Million
Q4 2020 Feb 09, 2021	BUY	$5.73 - $9.03 $179,727 - $283,234	31,366 Added 12.72%	277,996 $1.6 Million
Q3 2020 Nov 12, 2020	SELL	$3.32 - $7.24 $71,463 - $155,841	-21,525 Reduced 8.03%	246,630 $1.79 Million
Q2 2020 Aug 12, 2020	SELL	$1.41 - $4.25 $21,124 - $63,673	-14,982 Reduced 5.29%	268,155 $935,000
Q1 2020 May 06, 2020	BUY	$1.25 - $2.02 $2,691 - $4,349	2,153 Added 0.77%	283,137 $419,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $21,682 - $96,676	16,303 Added 6.16%	280,984 $550,000
Q3 2019 Nov 07, 2019	SELL	$5.12 - $7.21 $34,222 - $48,191	-6,684 Reduced 2.46%	264,681 $1.36 Million
Q2 2019 Aug 12, 2019	BUY	$6.05 - $13.66 $79,817 - $180,216	13,193 Added 5.11%	271,365 $1.94 Million
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $86,389 - $142,077	10,587 Added 4.28%	258,172 $3.43 Million
Q4 2018 Feb 11, 2019	SELL	$6.54 - $11.74 $76,688 - $137,663	-11,726 Reduced 4.52%	247,585 $1.95 Million
Q3 2018 Nov 09, 2018	BUY	$10.88 - $14.52 $182,827 - $243,994	16,804 Added 6.93%	259,311 $0
Q2 2018 Aug 06, 2018	BUY	$10.66 - $14.38 $1.22 Million - $1.64 Million	114,001 Added 88.71%	242,507 $3.25 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $154,953 - $261,009	-17,217 Reduced 11.81%	128,506 $1.67 Million
Q4 2017 Feb 09, 2018	BUY	$7.67 - $9.31 $1.12 Million - $1.36 Million	145,723	145,723 $1.34 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account